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Purpose: This study was designed to analyze two candidate genes, myocilin (MYOC) and cytochrome P450 1B1
(CYP1B1), in a Chinese pedigree of juvenile glaucoma with goniodysgenesis.
Methods: In a three-generation family of juvenile glaucoma with goniodysgenesis (13 members), six of them were patients
with  glaucoma  and  the  rest  were  asymptomatic.  All  members  of  the  family  underwent  complete  ophthalmologic
examinations. Exons of MYOC and CYP1B1 were amplified by polymerase chain reaction, sequenced, and compared with
a reference database.
Results: Elevated intraocular pressure (IOP) and visual function impairment was found in all patients, and goniodysgenesis
was noticed in five of them (nine eyes) with relatively transparent corneas. One MYOC heterozygous mutation, c.1109
C>T (P370L), in exon 3 was identified in all six patients but not in the asymptomatic family members. Two CYP1B1
single nucleotide polymorphisms (SNPs), g.3947 C>G (R48G) in exon 2 and 372−12 C>T in intron 1, were identified in
all six patients and but not in the asymptomatic family members except the proband’s grandmother. Three SNPs were
identified, 730 + 35 A>G in intron 2 of MYOC and g.8131 G>C (V432L) and g.8184 T>C (D449D) in exon 3 of
CYP1B1.
Conclusions: The presence of a P370L mutation of MYOC in all six glaucoma patients suggests a casual association
between this mutation and juvenile glaucoma with goniodysgenesis. The possible role of SNPs of CYP1B1 in the
pathogenesis of the disease remains to be elucidated.
Unlike  primary  open-angle  glaucoma  (POAG)  or
juvenile open-angle glaucoma (JOAG), juvenile glaucoma
can be associated with goniodysgenesis, a maldevelopment of
the iridocorneal angle of the eye [1,2]. If intraocular pressure
(IOP) becomes elevated after the age of three (late congenital
glaucoma), the patients may not present symptoms such as
buphthalmos, lacrimation, photophobia, and blepharospasm.
Genetic factors play a major role in the pathogenesis of
glaucoma, but the molecular basis still remains unknown. To
date, about 23 loci have been linked to different types of
glaucoma,  and  four  genes,  myocilin  (MYOC),  optineurin
(OPTN), cytochrome P450 1B1 (CYP1B1), and WD repeat
domain  36  (WDR36),  have  been  identified  as  glaucoma
causing  genes  [3-6].  MYOC  is  a  secreted  glycoprotein
normally expressed in several ocular and non-ocular tissues.
To date, more than 70 mutations have been detected in MYOC
in different population groups, contributing to approximately
3% of familial autosomal dominant adult-onset open-angle
glaucoma and a greater proportion of JOAG. Most of the
mutations were located in exon 3 where the olfactomedin-like
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domain is located [7]. Recently, mutations in MYOC have
been  linked  to  primary  congenital  glaucoma  in  India  and
China [8-10].
CYP1B1 has been shown to cause primary congenital
glaucoma (PCG), JOAG, and POAG [5,11-13]. It is thought
that CYP1B1 participates in the development of trabecular
meshwork (TM) of the eye [12]. CYP1B1 consists of three
exons of which only exons 2 and 3 encode the protein. So far,
certain sequence variances in CYP1B1 such as g.3947 C>G
(R48G) in exon 2 and 372−12 C>T in intron 1 have been
identified as single nucleotide polymorphisms (SNPs) based
on sequence analyses [14].
In this study, alterations in MYOC were analyzed, and a
known  mutation,  which  was  segregated  with  the  disorder
within the family and appeared to be the disease-causing gene,
was  found.  However,  this  still  cannot  explain  the
goniodysgenesis predominantly seen in patients of this family.
We  therefore  investigated  CYP1B1,  a  gene  known  to  be
related to the development of the iridocorneal angle [11].
Mutations in both MYOC and CYP1B1 have been found in the
juvenile or early-onset glaucoma pedigree. These mutations
are different from what we first reported in the study of a
juvenile glaucoma pedigree with goniodysgenesis, although
these mutations were previously reported in POAG and PCG.
Molecular Vision 2009; 15:1530-1536 <http://www.molvis.org/molvis/v15/a163>
Received 24 March 2009 | Accepted 4 August 2009 | Published 7 August 2009
© 2009 Molecular Vision
1530METHODS
Family  recruitment  and  clinical  examination:  A  three-
generation  family  with  juvenile  glaucoma  with
goniodysgenesis  was  recruited  from  the  clinic  of  the
Department  of  Ophthalmology  at  West  China  Hospital
(Sichuan University, Chengdu, P. R. China). The study was
approved by the medical ethics committee of the West China
Hospital of Sichuan University. This study adhered to the
tenets  of  the  Declaration  of  Helsinki.  All  subjects  were
clinically evaluated by glaucoma specialists and diagnosed
with juvenile glaucoma with goniodysgenesis.
Juvenile  glaucoma  with  goniodysgenesis  belongs  to
developmental glaucoma, which was defined as meeting all
of  the  following  criteria:  goniodysgenesis  with  secondary
causes (e.g., trauma, uveitis, or steroid-induced glaucoma)
excluded;  open  anterior  chamber  angle;  IOP  greater  than
21 mmHg in both eyes; and characteristic glaucomatous optic
disc damage and/or visual field loss. The pedigree structure
of the Chinese family with summaries of the variations in
MYOC and CYP1B1 is described in Figure 1.
DNA extraction: Genomic DNA was extracted from 200 μl
whole  blood  using  a  Qiamp  Blood  Kit  (Qiagen,  Hilden,
Germany). All the procedures were performed according to
the manufacturer’s protocol. DNA integrity was evaluated by
1% agarose gel electrophoresis.
PCR  amplification:  Intronic  primers  flanking  the  exons
(Table 1) were designed based on gene sequences of MYOC
(GenBank AF001620) and CYP1B1 (GenBank U56438) and
synthesized by Invitrogen (Carlsbad, CA). DNA fragments
were amplified by polymerase chain reaction (PCR) using a
MyCycler thermocycler (Bio-Rad, Hercules, CA). The 30 μl
PCR reaction mixture included 30 ng DNA, 1× PCR buffer,
2.5 mM MgCl2, 0.3 mM of each of dNTPs, 1.5 U Pfu DNA
polymerase, and 1.0 μM each of the forward and reverse
primers. All reagents used in this procedure were purchased
from MBI (MBI Fermentas, Vilnius, Lithuania). The reactions
were incubated in a 96 well plate at 95 °C for 2 min followed
by 30 cycles at 94 °C for 10 s, 54 °C–56 °C for 30s, and 72
°C for 1–2 min and then a final extension at 72 °C for 5 min.
Figure  1.  Pedigree  of  the  Chinese
glaucoma  family.  The  variations  of
MYOC  and  CYP1B1  genes  were
summarized in this figure of the Chinese
family  segregating  juvenile  glaucoma
with  goniodysgenesis.  The  MYOC
heterozygous mutation, C>T (P370L) in
exon 3 was identified in all six patients
but  not  in  asymptomatic  family
members.  Two  CYP1B1  SNPs,  C>G
(R48G) in exon 2 and C>T in intron 1,
were identified in all six patients and but
not  in  asymptomatic  family  members
except  the  proband’s  paternal
grandmother.  Abbreviations:  MY,
MYOC; CY, CYP1B1. Arrow indicates
the proband. (III:1).
TABLE 1. PRIMERS USED IN PCR FOR AMPLIFICATION OF MYOC AND CYP1B1.
Exons Primer sequence (forward/reverse) Product size (bp)
MYOC 1 5′-TCACCAAGCCTCTGCAATG-3′ 654
  5′-TGAACTCAGAGTCCCCCCAC-3′
MYOC 2 5′-GCACCTGCCACCACATCC-3′ 657
  5′-ACACATCTCTCATCTTGCCC-3′
MYOC 3 5′-GCTGTCACATCTACTGGCTC-3′ 927
  5′-ATCTCCTTCTGCCATTGCCT-3′
CYP1B1 2 5′-CATTTCTCCAGAGAGTCAGC-3′ 1260
  5′-GCTTGCAAACTCAGCATATTC-3′
CYP1B1 3 5′-ACCCAATGGAAAAGTCAGCC-3′ 927
  5′-GCTTGCCTCTTGCTTCTTATT-3′
The first column shows the sequenced exons of MYOC   and CYP1B1; the second column shows the primer sequences, both
forward and reverse ones, used to amplify the corresponding exons indicated in the first column; the third column shows the
expected size of the PCR products.
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1531Sequencing and data analysis: PCR products were directly
sequenced using an ABI 377XL automated DNA sequencer
(Applied Biosystems, Foster City, CA). Sequence data were
compared pair-wise with the published MYOC and CYP1B1
sequences.
RESULTS
The  proband:  The  proband  (III:1)  was  diagnosed  with
glaucoma (late stage, both eyes) at the age of 16 years. A cup-
disc ratio of 0.90–1.0, elevated IOP (42 mmHg in the right eye
and  34  mmHg  in  the  left  eye),  and  goniodysgenesis  as
described  below  were  observed.  No  other  ocular
abnormalities  or  systemic  disorders  were  found.
Trabeculectomy was performed for both eyes. Three years
after surgery, a cup-disc ratio of 0.95–1.0, open grade III
(Shaffer) angles, and late-stage glaucomatous visual field loss
were noticed in both eyes (Figure 2). His developmental angle
anomaly was characterized by the absence of the angle recess
in some area and the presence of iris tissue inserted either flat
or concave shaped directly into the trabecular meshwork all
over the iridocorneal angle.
Other  affected  family  members:  The  IOP  of  the  affected
members including the proband in this family varied between
25 mmHg and 55 mmHg, depending on different treatment
situations (no treatment, topical antiglaucoma medications,
and/or surgeries) for each individual. The proband’s father (II:
1) was diagnosed with glaucoma at 24 years of age. Six years
after the diagnosis, he became blind in both eyes. The father’s
two  younger  sisters  (II:3  and  II:4)  were  affected,  but  his
younger brother (II:6) was normal. The proband’s mother did
not have any ocular disorders, and she did not recall any
glaucoma cases among her lineage or relatives. The proband’s
paternal  grandfather  (I:1)  and  grandmother  (I:2)  had  a
consanguineous  marriage.  The  grandfather  (I:1)  has  had
glaucoma since he was young, and the grandmother (I:2)
never had glaucoma or other noticeable ocular disorders.
Goniodysgenesis as described in the proband was noticed
in four of his relatives with relatively transparent corneas.
None of the affected individuals showed an enlarged cornea,
excessive tearing, or photophobia. Table 2 is a summary of
the major clinical findings and the variations in MYOC and
CYP1B1 of the affected members in this family.
Asymptomatic  family  members:  The  proband’s  paternal
grandmother (I:2) was 65 years old, and her visual acuity was
20/25 with corrections. The visual acuities of the proband’s
paternal uncle (II:6) who was the only unaffected person in
the  second  generation  and  of  the  other  two  unaffected
individuals (III:3 and III:4) were 20/20. The IOP, anterior
chamber angle, and the cup-disc ratio of all asymptomatic
members were in normal ranges.
Sequencing results: The mutations that cosegregated with the
disorder within the family are summarized in Figure 1 and
Table 2.
MYOC—Sequence  analysis  of  MYOC  revealed  a
heterozygous mutation, C>T (P370L), in exon 3 in all patients
but not in any of the asymptomatic members of the family.
The P370L MYOC mutation cosegregated with the disorder
within the family. And one SNP of MYOC was identified in
intron 2 (A>G; Figure 3).
Figure 2. Clinical manifestations of the
proband.  A  and  B  showed  the
maldevelopment  of  the  anterior
chamber  angle.  C  and  D  showed
glaucomatous  optic  disc  atrophy  and
visual field defects, respectively.
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1532CYP1B1 —Two CYP1B1 SNPs, C>G (R48G) in exon 2
and  C>T  in  intron  1,  were  identified.  These  two  SNPs
occurred in all six patients afflicted with glaucoma (four were
heterozygous and two were homozygous) and were not found
in  any  of  the  asymptomatic  family  members  except  the
proband’s grandmother (Figure 4). Two SNPs were identified,
G>C (V432L) and T>C (D449D) both in exon 3 of CYP1B1
(Figure 5).
DISCUSSION
The terms congenital, developmental, infantile, and juvenile
glaucoma appear to be overlapping and confusing. Because
of a variation in the severity of angle abnormalities, glaucoma
may appear early or late in life. Therefore, it may not be
appropriate  to  decide  the  classification  or  the  mode  of
inheritance of the glaucoma based on the patient's age at the
onset of the symptoms when angle abnormality is the common
etiologic  factor  [1].  A  child  with  primary  glaucoma  but
without angle abnormalities should be diagnosed as JOAG.
Any childhood glaucoma caused by maldevelopment of the
iridocorneal  angle  is  considered  primary  congenital
glaucoma, which is usually characterized by buphthalmos,
lacrimation,  photophobia,  and  blepharospasm.  For  the
affected patients in this pedigree, these symptoms were not
noticed by either themselves or by ophthalmologists at the first
visit. No evidence is available for the exact ages when they
had glaucoma, but the onset of glaucoma is likely much earlier
than the time they noticed having eye problems. For example,
one of the patients (III:2) mentioned that he had “high myopia
TABLE 2. CLINICAL FINDINGS IN GLAUCOMA PATIENTS IN THIS THE FAMILY.
Sex/Age
Subject (years)
Highest IOP
(mmHg)
Observed
(OD/OS)
Cup-disc
ratio 
(OD/OS)
Visual
acuity 
(OD/OS)
Mutation                             SNPs
MYOC
P370L
CYP1B1
R48G
CYP1B1
 C>T
III:1 M/26 28/23 1.0/0.95 0.1/0.5 yes/yes het het het
III:2 M/22 25/44 1.0/1.0 NLP/NLP yes/yes het het het
II:1 M/41 52/NA 1.0/inv NLP/NLP yes/inv het hom hom
II:3 F/44 NA/50 inv/inv NLP/NLP inv/inv het hom hom
II:4 F/39 53/57 inv/inv NLP/NLP yes/yes het het het
I:1 M/71 34/30 1.0/1.0 NLP/ FC yes/yes het het het
The clinical information of the glaucoma patients in this pedigree were shown in this table, including gender, age, highest IOP,
cup-disc  ratio,  visual  acuity,  trabeculodisgenesis  and  sequence  variations  found  in MYOC   and CYP1B1.  In  the  table,
abbreviations are: M, male; F, female; OD, right eye; OS, left eye; IOP, intraocular pressure; NLP, no light perception; FC,
Figure counting; inv, invisible due to cornea opacification and/or cataract; het, heterozygous; hom, homozygous.
Figure 3. MYOC mutation and variation
in  the  glaucoma  family.  A:
Heterozygous C>T (P370L) mutation of
MYOC is shown. B: A>G variation of
MYOC is shown. Arrows indicate the
sequence difference, and the one in red
indicates the wild type sequence.
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Trabeculodysgenesisthat got worse very fast” when he was in primary school.
Cornea damage occurred in some of the patients probably due
to  long-term  uncontrolled  high  IOP.  A  gonioscopic
examination was performed for those eyes with relatively
transparent cornea, and all of them showed developmental
iridocorneal angle anomaly.
More than 70 mutations have been identified in MYOC
of  POAG  patients  from  India,  England,  France,  North
America,  Japan,  and  Germany,  indicating  that  different
MYOC  mutations  may  contribute  to  the  pathogenesis  of
POAG in populations of different ethnicity [15-22]. MYOC
mutations were also found in a few cases of sporadic PCG
[8,23]. Zhou et al. [24] reported the homozygous mutation in
intron 2 of MYOC in one family with both PCG and POAG in
China. In that pedigree, one was diagnosed as a PCG patient
who  developed  symptoms  of  epiphora,  photophobia,
edematous, enlarged cornea, and increased ocular axial length
while  the  anterior  chamber  angle  was  found  open  and
“normal”, and no maldevelopment of the iridocorneal angle
was  noticed  [24].  In  our  study,  MYOC  was  screened  for
mutations  in  the  pedigree  with  juvenile  glaucoma  with
goniodysgenesis.  P370L  as  a  heterozygous  mutation  was
identified in MYOC in the affected members but not in the
normal individuals, and the mutation cosegregated with the
disorder within the pedigree, suggesting that MYOC may be
the glaucoma-causing gene in this family.
However, the MYOC mutation does not support a role of
this gene in the maldevelopment of the iridocorneal angle.
Therefore, another candidate gene, CYP1B1, was screened.
Previous studies have identified CYP1B1 as a causative gene
in PCG and occasionally as a causative gene in POAG as well
as  several  anterior  segment  dysgenesis  disorders  [25].
Furthermore, CYP1B1-deficient mice exhibit abnormalities in
their  ocular  drainage  structure  and  trabecular  meshwork
(TM), which are similar to those reported in human PCG
patients [26]. It was speculated that the CYP1B1 protein might
be involved in the generation of a regulatory molecule that
controls the expression of genes involved in the development
of the anterior chamber angle [25]. In this pedigree, the R48G
variation in exon 2 and C>T variation in intron 1 of CYP1B1
were  found  in  all  six  patients  and  not  in  any  of  the
asymptomatic  family  members  except  the  proband’s
grandmother. We tried to compare the phenotypes between
the two patients homozygous for the CYP1B1 variation and
the others heterozygous for these variations. The former did
show  a  more  severe  and  complicated  phenotype  such  as
cataract. However, both of them received less antiglaucoma
treatments, which may explain the severity of the disorder.
Studies  by  Hollander  et  al.  [27]  have  indicated  that
multiple  CYP1B1  variances  in  which  the  R48G  was  not
included  may  be  associated  with  severe  or  moderate
goniodysgenesis  in  congenital  glaucoma.  In  our  pedigree
study,  individuals  carrying  both  the  MYOC  mutation  and
CYP1B1 variation were affected with juvenile glaucoma with
goniodysgenesis.  However,  it  is  still  unlikely  that  the
combination of MYOC and CYP1B1 variations correlate with
an earlier manifestation of the disease. The CYP1B1 variation
described in this study, C>G (R48G) in exon 2, has not been
reported to be associated with goniodysgenesis, and it was
identified as an SNP previously. Stoilov IR et al. [14] have
Figure  4.  Two  CYP1B1  SNPs  in  the
glaucoma family. A: C>G variation in
exon 2 of CYP1B1. The codon CGG in
exon 2 was replaced by GGG, resulting
in a change of amino acid from arginine
to glycine (R48G). B: C>T variation in
intron 1 of CYP1B1. These two SNPs
occurred in all six patients afflicted with
glaucoma,  and  were  not  found  in
asymptomatic family members except
the  proband’s  paternal  grandmother.
Arrows  indicate  the  sequence
difference, and the one in red indicates
the wild type sequence.
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populations in the UK and Turkey. It was also reported that
R48G variation frequency was 0.295 and 0.205 in patients
with primary congenital glaucoma and normal populations,
respectively, in Brazil, and the frequency variation was 0.435
and  0.39  in  patients  of  JOAG  and  normal  populations,
respectively,  in  India  [28,29].  Therefore,  this  variance
identified  in  this  pedigree  may  just  have  coincidentally
occurred in six patients. This is supported by the fact that this
variance was also found in the proband’s grandmother who
was asymptomatic.
In  conclusion,  the  P370L  mutation  of  MYOC  in  this
pedigree appears to be the cause of the disease. However, it
remains unclear the gene defect underlying goniodysgenesis
of the six patients with both a MYOC mutation and CYP1B1
variance. Previous studies indicated that CYP1B1 may act as
a modifier of MYOC expression and that the two genes may
interact via a common pathway [11,30]. Obviously, further
studies are needed to elucidate the possible role of CYP1B1
variations  such  as  R48G  in  juvenile  glaucoma  with
goniodysgenesis.
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